Research Article
Feasibility of Endoscopic Thyroidectomy via Axilla and Breast Approaches for Larger Goiters: Widening the Horizons
Table 1
Details of clinical presentation and demographic profile of patients.
| | S. No. | Parameter | Group I (n=60) | Group II (n=39) | P value |
| | 1 | Mean age (years) | 33.7 ± 11.3 | 34.9 ± 12.0 | 0.61 |
| | 2 | Gender ratio F:M | 50:8 (6.3:1) | 32:7 (4.6:1) | 0.28 |
| | 3 | Mean tumor size (cm) | 4.4 ± 0.9 | 6.7 ± 1.1 | 0.001 | | Range (cm) | 2.5-5.8 | 6-11 |
| | 4 | Duration of goitre (months) | 30.1 ± 32.6 | 60.5 ± 102.4 | 0.03 | | Range (months) | 1-144 | 2-480 |
| | 5 | Clinical diagnosis | (n=61) | (n=40) | | | | STN | 46 | 19 | | | | MNG-both lobes | 11 | 14 | | | | MNG-one lobe | 1 | 1 | | | | AFTN | 1 | 0 | | | | Graves’ disease | 0 | 1 | | | | Toxic MNG | 0 | 4 | | | | Postoperative histology of differentiated thyroid carcinoma (DTC) | 2 | 1 | |
| | 7 | Preoperative FNAC | | | | Not done | 3 | 1 | | | | Bethesda I | 1 | 1 | | | | Bethesda II | 44 | 30 | | | | Bethesda III | 3 | 3 | | | | Bethesda IV | 6 | 4 | | | | Bethesda V | 1 | 1 | | | | Bethesda VI | 3 | 0 | |
|
|
